Current treatment status-Not currently treated - Page 21 of 28 Posts on Medivizor
Navigation Menu

Current treatment status-Not currently treated Posts on Medivizor

Ipilumumab after surgery in high-risk stage III melanoma

Posted by on May 28, 2015 in Melanoma | 0 comments

In a nutshell The authors aimed to assess the effect of ipilimumab (Yervoy) as an additional therapy after surgery in advanced (stage III) melanoma patients who were at a high risk of relapse. Some background In the advanced stage of melanoma (stage III), cancer spreads from the skin to nearby lymph nodes (tiny, bean-shaped organs that help fight...

Read More

Erlotinib with pemetrexed and cisplatin for lung cancer that has spread to the brain

Erlotinib with pemetrexed and cisplatin for lung cancer that has spread to the brain

Posted by on May 19, 2015 in Lung cancer | 0 comments

In a nutshell The objective of this study was to evaluate the effect of erlotinib (Tarceva) in combination with pemetrexed (Alimta) and cisplatin (Platinol) in lung cancer that had spread into the brain (brain metastases). Some background Lung adenocarcinoma is the cancer of glandular cells of lungs. It is a common type of non-small cell lung...

Read More

Pembrolizumab versus ipilimumab in advanced melanoma

Pembrolizumab versus ipilimumab in advanced melanoma

Posted by on May 19, 2015 in Melanoma | 0 comments

In a nutshell The authors aimed to evaluate survival benefits of pembrolizumab (Keytruda) compared to ipilimumab (Yervoy) in advanced melanoma. Some background In the advanced stage of melanoma (stage III/IV), cancer spreads from the skin to other parts of the body. One of the standard treatments for advanced melanoma is immunotherapy that uses...

Read More

Racotumomab vaccine : a maintenance therapy in advanced non-small cell lung cancer

Racotumomab vaccine : a maintenance therapy in advanced non-small cell lung cancer

Posted by on May 12, 2015 in Lung cancer | 0 comments

In a nutshell The objective of this research was to analyze the safety and effectiveness of racotumomab (Vaxira) vaccine in advanced non-small cell lung cancer (NSCLC). Some background In the advanced stage (IIB/ IV) of NSCLC, cancer may spread throughout lungs, to adjacent lymph nodes (tiny, bean-shaped organs that help fight infections) and to...

Read More

Can we estimate the benefit of vandetanib and docetaxel in advanced non-small cell lung cancer?

Can we estimate the benefit of vandetanib and  docetaxel in advanced non-small cell lung cancer?

Posted by on May 12, 2015 in Lung cancer | 0 comments

In a nutshell The aim of this study was to determine whether the benefit from combination therapy of vandetanib (Caprelsa) and docetaxel (Taxotere) could be linked to specific biological substances in non-small cell lung cancer (NSCLC) patients. Some background In advanced stage (IIB/IV) NSCLC, cancer may spread throughout lungs and to other...

Read More

Interleukin-2 can improve survival in skin cancer patients

Posted by on Apr 21, 2015 in Melanoma | 0 comments

In a nutshell The authors aimed to determine the effect of interleukin-2 in treating in-transit skin cancer.  Some background In-transit skin cancer is cancer that has progressed into the lymph nodes (sites that hold the immune cells) from the primary site of cancer. Interleukin-2 (IL-2, Proleukin,  Aldesleukin) is a man-made protein...

Read More